<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
--------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported) January 13, 1997
URETHANE TECHNOLOGIES, INC.
- --------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in its Charter)
Nevada 1-11600 33-0126369
- --------------------------------------------------------------------------------
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
212 West Taft, Orange, California 92866
- --------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (714) 921-2300
<PAGE> 2
ITEM 9. SALES OF EQUITY SECURITIES PURSUANT TO REGULATION S
Urethane Technologies, Inc. (the "Company") sold 4 Convertible
Debentures at a price of $25,000 per Convertible Debenture on
January 13, 1997 and sold 1 Convertible Debenture at a price
of $15,000 on January 17, 1997. The Offering was made on
behalf of the Company by Astor Capital as placement agent and
was made to non-U.S. persons (as defined in Regulation S).
The Offering raised an aggregate of $115,000, of which the
placement agent received a commission of seven percent of the
first one hundred thousand dollars and ten percent thereafter.
The Convertible Debentures are convertible into shares of
common stock at the lesser of certain discount to the bid price
of the common stock at the date of the sale of the Convertible
Debenture or a different discount to the bid price of the
common stock at the date of conversion. The Offering was made
in reliance on Regulation S promulgated under the Securities
Act of 1933, based on the fact that the Company is a reporting
issuer pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934, the offer and sale of the Convertible
Debentures were made in an offshore transaction (as defined in
Regulation S), and no direct selling efforts were made in the
United States by the Company, a distributor, any of their
respective affiliates, or any person acting on behalf of any of
the foregoing.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Dated: January 27, 1997 URETHANE TECHNOLOGIES, INC.
By: /s/ James B. Frakes
---------------------------------
James B. Frakes,
Chief Financial Officer
